Is Hologic (HOLX) Halal?
Shariah Screening — 5 Standards
Based on financial data from September 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 15.5% / 30% | 13.0% / 30% | 3.6% / 30% | 1.81% / 5% | ✓ HALAL |
| DJIM | 15.5% / 33% | 13.0% / 33% | 3.6% / 33% | 1.81% / 5% | ✓ HALAL |
| MSCI | 29.1% / 33% | 24.4% / 33% | 6.7% / 33% | 1.81% / 5% | ✓ HALAL |
| S&P | 15.5% / 33% | 13.0% / 33% | 3.6% / 33% | 1.81% / 5% | ✓ HALAL |
| FTSE | 29.1% / 33% | 24.4% / 33% | 6.7% / 50% | 1.81% / 5% | ✓ HALAL |
Financial Highlights
Profitability
| Gross Margin | 60.4% | |
| Operating Margin | 23.0% | |
| Net Margin | 13.2% | |
| Return on Equity (ROE) | 10.9% | |
| Return on Assets (ROA) | 7.4% |
Cash Flow & Balance Sheet
| Operating Cash Flow | $1.1B |
| Free Cash Flow | $905M |
| Total Debt | $2.6B |
| Debt-to-Equity | 48.1 |
| Current Ratio | 4.0 |
| Total Assets | $9.0B |
Price & Trading
| Last Close | $75.69 |
| 50-Day MA | $75.22 |
| 200-Day MA | $71.00 |
| Avg Volume | 2.8M |
| Beta | 0.7 |
|
52-Week Range
$51.90
| |
About Hologic (HOLX)
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. It also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analysis software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology systems; and breast conserving surgery products. In addition, the company provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system. The company sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Purification Calculator
As a halal stock with 1.81% impermissible income, you need to purify your dividends.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Hologic (HOLX) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Hologic is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Hologic's debt ratio?
Hologic's debt ratio is 15.5% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 29.1%.
Does Hologic require dividend purification?
Yes, Hologic has an impermissible income ratio of 1.81%, which means 1.81% of any dividends received should be donated to charity as purification. This is because a small portion of the company's revenue comes from non-Shariah-compliant sources.
What are Hologic's key financial metrics?
Hologic has a market capitalization of $16.9B, trailing P/E ratio of 31.4, and revenue of $4.1B. The company maintains a gross margin of 60.4% and a net margin of 13.2%. Return on equity stands at 10.9%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.